Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease

NCT00815919 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Chronic Graft Versus Host Disease

Interventions

DRUG: bortezomib
DRUG: Prednisone

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]